Life Science Alliance,
Journal Year:
2023,
Volume and Issue:
6(7), P. e202301969 - e202301969
Published: April 11, 2023
A
soluble
ACE2
protein
bioengineered
for
long
duration
of
action
and
high
affinity
to
SARS-CoV-2
was
administered
either
intranasally
(IN)
or
intraperitoneally
(IP)
SARS-CoV-2–inoculated
k18hACE2
mice.
This
decoy
(ACE2
618-DDC-ABD)
given
IN
IP,
pre-
post-inoculation,
IN,
+
IP
but
only
post-inoculation.
Survival
by
day
5
0%
in
untreated
mice,
40%
the
IP-pre,
90%
IN-pre
group.
In
group,
brain
histopathology
essentially
normal
lung
significantly
improved.
Consistent
with
this,
titers
were
undetectable
reduced
When
618-DDC-ABD
survival
30%
20%
We
conclude
that
results
markedly
improved
provides
organ
protection
when
as
compared
systemically
after
viral
inoculation,
lowering
is
a
critical
determinant
protection.
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Jan. 7, 2025
Abstract
The
mucosal
immune
system,
as
the
most
extensive
peripheral
network,
serves
frontline
defense
against
a
myriad
of
microbial
and
dietary
antigens.
It
is
crucial
in
preventing
pathogen
invasion
establishing
tolerance.
A
comprehensive
understanding
immunity
essential
for
developing
treatments
that
can
effectively
target
diseases
at
their
entry
points,
thereby
minimizing
overall
impact
on
body.
Despite
its
importance,
our
knowledge
remains
incomplete,
necessitating
further
research.
outbreak
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
underscored
critical
role
disease
prevention
treatment.
This
systematic
review
focuses
dynamic
interactions
between
mucosa-associated
lymphoid
structures
related
diseases.
We
delve
into
basic
functions
these
tissues
during
processes
explore
intricate
regulatory
networks
mechanisms
involved.
Additionally,
we
summarize
novel
therapies
clinical
research
advances
immunity-related
also
addresses
challenges
vaccines,
which
aim
to
induce
specific
responses
while
maintaining
tolerance
non-pathogenic
microbes.
Innovative
therapies,
such
nanoparticle
vaccines
inhalable
antibodies,
show
promise
enhancing
offer
potential
improved
Cell Reports,
Journal Year:
2023,
Volume and Issue:
42(4), P. 112271 - 112271
Published: March 7, 2023
In
November
2021,
Omicron
BA.1,
containing
a
raft
of
new
spike
mutations,
emerged
and
quickly
spread
globally.
Intense
selection
pressure
to
escape
the
antibody
response
produced
by
vaccines
or
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection
then
led
rapid
succession
sub-lineages
with
waves
BA.2
BA.4/5
infection.
Recently,
many
variants
have
such
as
BQ.1
XBB,
which
carry
up
8
additional
receptor-binding
domain
(RBD)
amino
acid
substitutions
compared
BA.2.
We
describe
panel
25
potent
monoclonal
antibodies
(mAbs)
generated
from
vaccinees
suffering
breakthrough
infections.
Epitope
mapping
shows
mAb
binding
shifting
3
clusters,
corresponding
early-pandemic
hotspots.
The
RBD
mutations
in
recent
map
close
these
sites
knock
out
severely
down
neutralization
activity
all
but
1
mAb.
This
corresponds
large
falls
titer
vaccine
BA.2,
immune
serum.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 28, 2024
Abstract
Under
pressure
from
neutralising
antibodies
induced
by
vaccination
or
infection
the
SARS-CoV-2
spike
gene
has
become
a
hotspot
for
evolutionary
change,
leading
to
failure
of
all
mAbs
developed
clinical
use.
Most
potent
bind
receptor
binding
domain
which
heavily
mutated.
Here
we
study
responses
conserved
epitope
in
sub-domain-1
(SD1)
have
more
prominent
because
mutational
escape
directed
domain.
Some
SD1
reactive
show
and
broad
neutralization
variants.
We
structurally
map
dominant
provide
mechanism
action
blocking
interaction
with
ACE2.
Mutations
not
been
sustained
date,
but
one,
E554K,
leads
mAbs.
This
mutation
now
emerged
several
sublineages
including
BA.2.86,
reflecting
selection
on
virus
exerted
increasing
prominence
anti-SD1
response.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 4, 2025
Abstract
Accurate
identification
of
single‐nucleotide
variants
(SNVs)
is
paramount
for
disease
diagnosis.
Despite
the
facile
design
DNA
hybridization
probes,
their
limited
specificity
poses
challenges
in
clinical
applications.
Here,
a
differential
reaction
pathway
probe
(DRPP)
based
on
dynamic
network
presented.
DRPP
leverages
differences
intermediate
concentrations
between
SNV
and
WT
groups,
directing
them
into
distinct
pathways.
This
generates
strong
pulse‐like
signal
weak
unidirectional
increase
wild‐type
(WT).
Through
application
machine
learning
to
fluorescence
kinetic
data
analysis,
classification
signals
automated
with
an
accuracy
99.6%,
significantly
exceeding
80.7%
conventional
methods.
Additionally,
sensitivity
variant
allele
frequency
(VAF)
enhanced
down
0.1%,
representing
ten‐fold
improvement
over
approaches.
accurately
identified
D614G
N501Y
SNVs
S
gene
SARS‐CoV‐2
patient
swab
samples
99%
(n
=
82).
It
determined
VAF
ovarian
cancer‐related
mutations
KRAS‐G12R
,
NRAS‐G12C
BRAF‐V600E
both
tissue
blood
77),
discriminating
cancer
patients
healthy
individuals
significant
difference
(
p
<
0.001).
The
potential
integration
diagnostics,
along
rapid
amplification
techniques,
holds
promise
early
diagnostics
personalized
diagnostics.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Feb. 29, 2024
The
rapid
emergence
and
global
dissemination
of
the
Omicron
variant
SARS-CoV-2
have
posed
formidable
challenges
in
public
health.
This
scenario
underscores
urgent
need
for
an
enhanced
understanding
Omicron's
pathophysiological
mechanisms
to
guide
clinical
management
shape
health
strategies.
Our
study
is
aimed
at
deciphering
intricate
molecular
underlying
infections,
particularly
focusing
on
identification
specific
biomarkers.
Emerging Microbes & Infections,
Journal Year:
2022,
Volume and Issue:
11(1), P. 2749 - 2761
Published: Oct. 26, 2022
SARS-CoV-2
variants
continue
to
emerge
facing
established
herd
immunity.
L452R,
previously
featured
in
the
Delta
variant,
quickly
emerged
Omicron
subvariants,
including
BA.4/BA.5,
implying
a
continued
selection
pressure
on
this
residue.
The
underlying
links
between
spike
mutations
and
their
selective
pressures
remain
incompletely
understood.
Here,
by
analyzing
221
structurally
characterized
antibodies,
we
found
that
IGHV1-69-encoded
antibodies
preferentially
contact
L452
using
germline-encoded
hydrophobic
residues
at
tip
of
HCDR2
loop.
Whereas
somatic
hypermutations
or
VDJ
rearrangements
are
required
acquire
L452-contacting
for
non-IGHV1-69
encoded
antibodies.
Antibody
repertoire
analysis
revealed
IGHV1-69
antibody
lineages
commonly
induced
among
COVID-19
convalescents
but
exhibit
limited
prevalence.
In
addition,
experimentally
demonstrated
L452R
renders
most
published
ineffective.
Furthermore,
enriched
experienced
BA.1
(without
L452R)
breakthrough
infections
rarely
(with
infections.
Taken
together,
these
findings
support
population
contribute
substitution.
This
study
thus
provides
better
understanding
variant
genesis
immune
evasion.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Feb. 24, 2023
SARS-CoV-2
Omicron
variants
feature
highly
mutated
spike
proteins
with
extraordinary
abilities
in
evading
antibodies
isolated
earlier
the
pandemic.
Investigation
of
memory
B
cells
from
patients
primarily
breakthrough
infections
Delta
variant
enables
isolation
a
number
neutralizing
cross-reactive
to
heterologous
concern
(VOCs)
including
(BA.1-BA.4).
Structural
studies
identify
altered
complementarity
determining
region
(CDR)
amino
acids
and
unusual
heavy
chain
CDR2
insertions
respectively
two
representative
cross-neutralizing
antibodies-YB9-258
YB13-292.
These
features
are
putatively
introduced
by
somatic
hypermutation
they
heavily
involved
epitope
recognition
broaden
neutralization
breadth.
Previously,
insertions/deletions
were
rarely
reported
for
antiviral
except
those
induced
HIV-1
chronic
infections.
data
provide
molecular
mechanisms
cross-neutralization
infected
implications
future
vaccination
strategy.
Life Science Alliance,
Journal Year:
2023,
Volume and Issue:
6(9), P. e202201796 - e202201796
Published: July 4, 2023
SARS-CoV-2
spike
protein
(S)
is
structurally
dynamic
and
has
been
observed
by
cryo-EM
to
adopt
a
variety
of
prefusion
conformations
that
can
be
categorized
as
locked,
closed,
open.
S-trimers
adopting
locked
are
tightly
packed
featuring
structural
elements
incompatible
with
RBD
in
the
“up”
position.
For
S,
it
shown
transient
under
neutral
pH.
Probably
because
their
transience,
remain
largely
uncharacterized
for
SARS-CoV-1
S.
In
this
study,
we
introduced
x1,
x2,
x3
disulfides
into
Some
these
have
preserve
rare
when
Introduction
allowed
us
image
other
S
cryo-EM.
We
identified
bound
cofactors
features
associated
conformations.
compare
newly
determined
structures
available
SARS-related
CoVs
identify
conserved
discuss
possible
functions.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 11, 2024
Abstract
In
the
ENSEMBLE
randomized,
placebo-controlled
phase
3
trial
(NCT04505722),
estimated
single-dose
Ad26.COV2.S
vaccine
efficacy
(VE)
was
56%
against
moderate
to
severe–critical
COVID-19.
SARS-CoV-2
Spike
sequences
were
determined
from
484
and
1,067
placebo
recipients
who
acquired
this
set
of
prespecified
analyses,
we
show
that
in
Latin
America,
VE
significantly
lower
Lambda
vs.
Reference
non-Lambda
[family-wise
error
rate
(FWER)
p
<
0.05].
differed
by
residue
match
mismatch
vaccine-insert
at
16
amino
acid
positions
(4
FWER
0.05;
12
q-value
≤
0.20);
decreased
with
physicochemical-weighted
Hamming
distance
vaccine-strain
sequence
for
Spike,
receptor-binding
domain,
N-terminal
S1
(FWER
0.001);
0.05)
strain
measured
9
antibody-epitope
escape
scores
4
NTD
neutralization-impacting
features;
(p
=
0.011)
neutralization
resistance
level
vaccinee
sera.
COVID-19
stable
across
most
features
but
distant
viruses.